Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Angiotensin 1/2 (1-6) in RAS Research
2026-09-15
Angiotensin 1/2 (1-6) gives cardiovascular and renal researchers a defined Asp-Arg-Val-Tyr-Ile-His hexapeptide for controlled studies of vascular tone, aldosterone-linked signaling, and peptide-dependent molecular interactions. A structured workflow also makes the fragment useful for testing emerging renin-angiotensin system links to viral receptor-binding assays without confusing biochemical binding with clinical or infectious outcomes.
-
2-Thio-dCTP: A Mechanistic Assay Framework
2026-09-15
2-Thio-dCTP enables controlled studies of DNA polymerase specificity, site-specific DNA modification, and DNA–protein recognition. This article develops a distinct assay framework that connects nucleotide chemistry with the SCP4–H3T3 chromosome-stability pathway while clearly separating established evidence from testable experimental opportunities.
-
Protease Inhibitor Cocktail for Phospho-Proteomics
2026-09-14
Protect labile proteins during cell and tissue lysis without introducing EDTA into cation-dependent assays. This workflow shows how an EDTA-free cocktail supports Western blotting, immunoprecipitation, kinase assays, and orthogonal validation of prostate cancer stem-cell metabolism.
-
Improved Amplex Red Assay for CYP119 Engineering
2026-09-14
This study developed an Amplex Red peroxidation assay for rapid screening of hydrogen peroxide-dependent cytochrome P450 activity in cell lysates. Screening of a CYP119 active-site library identified the T213R/T214I variant, which combined stronger Amplex Red peroxidation with improved styrene epoxidation and greater resistance to peroxide-associated heme degradation.
-
Clasto-Lactacystin β-lactone Workflow Guide
2026-09-13
Use Clasto-Lactacystin β-lactone to test whether protein turnover drives RIPK3 stability, necroptosis, and virus-associated inflammation. This workflow combines reversible experimental logic with the compound’s cell permeability and irreversible proteasome engagement for stronger pathway attribution.
-
ALDH2 Activation Delays Heart Failure in Mice
2026-09-12
A 2025 Experimental Cell Research study identifies ALDH2 as more than an oxidative-stress defense enzyme: its activation extended the early postnatal proliferative window of mouse cardiomyocytes and delayed pressure overload-induced heart failure in adults. The findings provide a mechanistic rationale for studying ALDH2 in cardiac regeneration, while leaving the durability, molecular pathway, and relevance to human disease unresolved.
-
Storage Optimization for LNP Self-Replicating RNA Vaccines
2026-09-11
Kim et al. systematically evaluated how temperature, buffer composition, cryoprotection, and lyophilization affect lipid nanoparticle-formulated self-replicating RNA vaccines. Their central finding was that an RNase-free PBS formulation containing 10% sucrose and stored at −20 °C preserved structural integrity and in vivo potency for 30 days, while freeze-drying also retained bioactivity.
-
Carvedilol Phosphate for Hepatic IRI Research
2026-09-11
Carvedilol Phosphate provides a practical beta-adrenergic perturbation tool for linking GPCR signaling with hepatocyte stress, macrophage polarization, and metabolite responses. This guide translates the Arrb2–6-ketoLCA hepatic IRI findings into controlled cell-based workflows while clearly separating literature evidence from pilot protocol recommendations.
-
Cyclic Pifithrin-α hydrobromide Workflow
2026-09-10
Cyclic Pifithrin-α hydrobromide enables controlled p53 pathway inhibition in apoptosis, DNA-damage, and radioprotection assays. This guide shows how to apply it as a mechanistic probe alongside the CGRP/SP–Piezo2 neuroinflammation model while avoiding unsupported therapeutic conclusions.
-
TG003: From Splice Control to CLK2 Translation
2026-09-10
TG003 offers a reversible way to interrogate Clk-dependent splicing while opening a disciplined translational path toward CLK2 biology, platinum resistance, and exon-skipping research.
-
PreScission Protease (PSP) Workflow Guide
2026-09-09
PreScission Protease (PSP), SKU K1101, is a recombinant HRV 3C protease fusion enzyme for removing affinity tags from recombinant proteins at low temperature. It is appropriate when the defined cleavage sequence is present and accessible, but it should not be treated as a universal protease or used to support performance claims beyond the supplied product dossier.
-
TG003 Cdc2-like Kinase Inhibitor: Research Workflows
2026-09-09
TG003 is a practical ATP-competitive tool for linking Clk-dependent serine/arginine-rich protein phosphorylation to measurable changes in alternative splicing. Its value extends from splice site selection research and exon-skipping models to hypothesis-driven studies of CLK2-associated platinum resistance, provided dose, target engagement, and off-target controls are carefully managed.
-
Targeted Doxycycline Nanoparticles for AAA Therapy
2026-09-08
The reference study develops cRGD-functionalized tea polyphenol nanoparticles that deliver Doxycycline selectively to abdominal aortic aneurysm lesions. This design combines ROS-responsive release, antioxidant carrier activity, and matrix metalloproteinase inhibition to address several pathological processes while reducing doxycycline-associated hepatic and renal toxicity in preclinical models.
-
Meropenem trihydrate for Resistance Research
2026-09-08
Meropenem trihydrate supports controlled antibacterial assays, resistance phenotyping, and metabolomics workflows against clinically relevant Enterobacterales. This guide connects its formulation characteristics with a rapid LC-MS/MS strategy that distinguished carbapenemase-producing isolates in under 7 hours.
-
Angiopoietin–PEDF Control of Retinal Neuron Survival
2026-09-07
Younis and colleagues identify a Müller cell–mediated pathway in which Ang-1 and Ang-2 oppositely regulate Tie-2–PI3K/Akt signaling, PEDF production, and retinal cell survival. The study’s co-culture and loss-of-function design shifts attention from direct neuronal angiopoietin responses toward glia-dependent neurovascular regulation, with implications for hypoxic retinal injury research.